F-18-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib

Ahmaddy, F; Burgard, C; Beyer, L; Koehler, VF; Bartenstein, P; Fabritius, MP; Geyer, T; Wenter, V; Ilhan, H; Spitzweg, C; Todica, A

Todica, A (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, D-81377 Munich, Germany.; Todica, A (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Canc Ctr CCC LMU, D-81377 Munich, Germany.; Todica, A (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Interdisciplinary Ctr Thyroid Carcinoma ISKUM, D-81377 Munich, Germany.

CANCERS, 2021; 13 (2):

Abstract

Simple Summary In patients with advanced radioiodine refractory differentiated thyroid carcinoma (DTC), therapeutic options are limited. In the "Study......

Full Text Link